# Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study

> **NCT01077401** · PHASE2 · COMPLETED · sponsor: **Johns Hopkins University** · enrollment: 152 (actual)

## Conditions studied

- Diabetic Macular Edema

## Interventions

- **DRUG:** Ranibizumab
- **DRUG:** ranibizumab

## Key facts

- **NCT ID:** NCT01077401
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02
- **Primary completion:** 2012-03
- **Final completion:** 2013-03
- **Target enrollment:** 152 (ACTUAL)
- **Last updated:** 2017-04-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01077401

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01077401, "Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01077401. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*